Valid for Submission
C93.12 is a billable diagnosis code used to specify a medical diagnosis of chronic myelomonocytic leukemia, in relapse. The code C93.12 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
Diagnostic Related Groups - MS-DRG Mapping
Convert C93.12 to ICD-9 Code
Information for Patients
Chronic Myeloid Leukemia
Also called: CML, Chronic granulocytic leukemia, Chronic myelogenous leukemia
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In chronic myeloid leukemia (CML), there are too many granulocytes, a type of white blood cell.
Most people with CML have a gene mutation (change) called the Philadelphia chromosome.
Sometimes CML does not cause any symptoms. If you have symptoms, they may include:
- Weight loss
- Night sweats
- Pain or a feeling of fullness below the ribs on the left side
Tests that examine the blood and bone marrow diagnose CML. Treatments include chemotherapy, stem cell transplants, infusion of donated white blood cells following stem cell transplants, surgery to remove the spleen, and biologic and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.
NIH: National Cancer Institute
- After chemotherapy - discharge (Medical Encyclopedia)
- Bone marrow transplant (Medical Encyclopedia)
- Bone marrow transplant - discharge (Medical Encyclopedia)
- Chronic myelogenous leukemia (CML) (Medical Encyclopedia)
[Learn More in MedlinePlus]